Number of items: 5.
2012
Carlin , C., Celnik, D., Pak, O., Wadsworth, R., Peacock, A., and Welsh, D.
(2012)
Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension.
American Journal of Respiratory Cell and Molecular Biology, 47
(2).
pp. 140-148.
ISSN 1044-1549
(doi:10.1165/rcmb.2011-0411OC)
2009
Weerackody, R. P., Welsh, D. J., Wadsworth, R. M., and Peacock, A. J.
(2009)
Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction.
AJP: Heart and Circulatory Physiology, 296
(5).
H1312-H1320.
ISSN 0363-6135
(doi:10.1152/ajpheart.00977.2008)
2008
Dempsie, Y. et al.
(2008)
Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice.
Circulation, 117
(22).
pp. 2928-2937.
ISSN 0009-7322
(doi:10.1161/CIRCULATIONAHA.108.767558)
Syyed, R., Reeves, J. T., Welsh, D., Raeside, D., Johnson, M. K., and Peacock, A. J.
(2008)
The Relationship Between the Components of Pulmonary Artery Pressure Remains Constant Under All Conditions in Both Health and Disease.
Chest, 133
(3).
pp. 633-639.
ISSN 0012-3692
(doi:10.1378/chest.07-1367)
2007
Carlin, C., Peacock, A., and Welsh, D.
(2007)
Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts.
American Journal of Respiratory Cell and Molecular Biology, 37
(4).
pp. 447-456.
ISSN 1044-1549
(doi:10.1165/rcmb.2007-0012OC)
This list was generated on Thu Jun 20 08:36:35 2013 BST.
